Disclosed herein are compositions comprising: a pharmaceutically acceptable oxidizing agent； a pharmaceutically acceptable base； and a pharmaceutically acceptable solvent or mixture of solvents. Also disclosed are methods of treating urushiol-induced contact dermatitis in a patient, the method comprising: identifying a patient in need thereof； and administering to the patient a composition as described herein. Further disclosed herein are devices for the treatment of urushiol-induced contact dermatitis, the device comprising: an absorbent material, contained therein a composition as described herein； and means for attaching the device to the skin of a patient in need thereof.
